Cytomel (Pfizer Laboratories Div Pfizer Inc)
Welcome to the PulseAid listing for the Cytomel drug offered from Pfizer Laboratories Div Pfizer Inc. This l-Triiodothyronine [EPC],Triiodothyronine [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc |
| NON-PROPRIETARY NAME: | liothyronine sodium |
| SUBSTANCE NAME: | LIOTHYRONINE SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | l-Triiodothyronine [EPC],Triiodothyronine [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1956-05-08 |
| END MARKETING DATE: | 0000-00-00 |
Cytomel HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cytomel from Pfizer Laboratories Div Pfizer Inc |
| LABELER NAME: | Pfizer Laboratories Div Pfizer Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(ug/1) |
| START MARKETING DATE: | 1956-05-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 60793-115_a0a9703d-e476-4207-b0e6-3348d68c2f60 |
| PRODUCT NDC: | 60793-115 |
| APPLICATION NUMBER: | NDA010379 |
Other LIOTHYRONINE SODIUM Pharmaceutical Manufacturers / Labelers:
